PBM reform, Medicare Advantage exits, and the 340B rebate pilot are reshaping drug access. Here is what payers need to know heading into 2027.
News|Articles|August 3, 2026
LGBTQ+ Medical Students Favor States With Protections
Author(s)Maggie L. Shaw
Fact checked by: Laura Joszt, MA
The researchers of this study warn a mismatch could deepen care gaps for LGBTQ+ patients in restrictive states.
Advertisement
Advertisement
Sexual and gender minority (SGM) medical students have 56% higher odds than their non-SGM peers to prefer training in states with stronger legal protections for
Related to this article
Initial frontal fibrosing alopecia treatment was largely similar in Black and White patients, though tetracycline use was higher in Black patients.
HHS does not intend to take enforcement action against pharmacies compounding BPC-157 and 5 other unapproved peptides if they meet 10 conditions.
Early modeling put sickle cell gene therapy coverage near 11 cents per member per month.
Experts at AMCP Nexus say biosimilar launches should prompt payers to revisit step therapy and measure value beyond market share.
AI in myeloproliferative neoplasms can grade marrow fibrosis and predict survival, but authors say prospective, outcome-focused trials are needed first.
Costs of multimorbidity in older adults are climbing faster than its disability toll, and study authors say policy should look past single-disease programs.
October's FDA approvals included the introduction of 5 non-oncology treatment options across specialties.
Advertisement
Advertisement